21 – 30 of 84
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
White adipose tissue browning in the R6/2 mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Immunomodulation - a disease-modifying avenue for treatment of Huntington's disease?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin
(
- Contribution to journal › Article
-
Mark
Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease : increased NPY levels and differential degradation of the NPY1-30 fragment
(
- Contribution to journal › Article
-
Mark
L23 Effects of peripheral (co-)administration of liraglutide and ghrelin in the R6/2 mouse brain function
2016) European Huntington Disease Network conference 2016 In Journal of Neurology, Neurosurgery and Psychiatry 87(Suppl 1). p.98-98(
- Contribution to journal › Published meeting abstract
-
Mark
L24 The effect of ghrelin administration in the R6/2 mouse model of Huntington’s disease
2016) European Huntington Disease Network conference 2016 In Journal of Neurology, Neurosurgery and Psychiatry 87(Suppl 1).(
- Contribution to journal › Published meeting abstract
-
Mark
A Metabolic Study of Huntington's Disease.
(
- Contribution to journal › Article
- 2015
-
Mark
A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Characterization of Gastric Mucosa Biopsies Reveals Alterations in Huntington's Disease.
(
- Contribution to journal › Article